Expression and processingof the human immunodeficiency virus type 1 envelope glycoprotein

Intervirology

Volumn 39, Issue 4, 1996, Pages 242-248

  Chen, Steve S L ^a  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

Envelope glycoprotein; Human immunodeficiency virus type 1; Precursor processing; Vaccinia late P11 promoter; Vesicular stomatitis virus coinfection

Indexed keywords

GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 160; PROTEIN PRECURSOR; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CULTURE MEDIUM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; SYNCYTIUM; VACCINIA; VESICULAR STOMATITIS VIRUS;

EID: 0030513065     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000150524     Document Type: Article

References (27)

1. McCune JM, Rabin LB, Fcinbcrg MB, Lieber-man M, Kosek JC, Reyes GR, Weissman IL: Endoproteolvtic cleavage of gpl60 is required for the activation of human immunodeficiency virus, Cell 1988:53:55-67.
2. Willey RL, Bonifacino JS, Potts BJ, Martin MA, Klausner RD: Biosynthesis, cleavage, and degradation of the human immunodeficiency virus I envelope glycoprotein gp 160. ProcNatl Acad Sci USA 1988:85:9580-9584.
3. Dewar RL, Vasudcvachari MB, Natarajan V, Salzman NP: Biosynthesis and processing of human immunodeficiency virus type 1 envelope glycoproteins: Effects of monensin on gly-cosylation and transport, J Virol 1989;63: 2452-2456.
4. Stein BS, Englcman EG: Intracellular processing of the gpl60 HIV-1 envelope precursor: Endoprotcolytic cleavage occurs in a cis or medial compartment of the Golgi complex, J Biol C'hem 1990:265:2640-2649.
5. Earl PL, Moss B, Dorns RW: Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein, J Virol 1991:65:2047-2055.
6. Hallenbcrger S, Bosch V, Anglikcr H, Shaw E, Klenk HD, Garten W: Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gpl60. Nature 1992:360:358-361.
7. McDougal JS, Nicholson JKA, Cross GD, Cort SP, Kennedy MS, Mawle AC: Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: Conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry, J Immunol 1986;137:2937-2944.
8. Kowalski M, Potz J, Basiripour L, Dorfman T, Goh WC, Terwilligcr E, Dayton A, Rosen C, I lascltinc W, Sodroski J: Functional regions of envelope glycoprotein of human immunodeficiency virus type 1. Science 1987:237:1351-1355.
9. Zhu Z, Chen SSL, Huang AS: Phenotypic mixing between human immunodeficiency virus and vesicular stomatitis virus or herpes simplex virus, J Acquir Immune Defie Syndr 1990: 3:215-219.
10. Huang AS, Wagner RR: Inhibition of cellular RNA synthesis by nonrcplicating vesicular stomatitis virus, Proc Natl Acad Sci USA 1965; 54:1579-1584.
11. Yaoi Y, Amano M: Inhibiting effect of ultraviolet-inactivated vesicular stomatitis virus in initiation of DNA synthesis in cultured chick embryo cell, J Gen Virol 1970:9:69-75.
12. Davoust J, Gruenberg J, Howell KE: Two threshold valuesoflowpH blockcndocytosisat different stages, EMBOJ 1987;6:3601-3609.
13. Matlin KS, Skibbens J, McNeil PL: Reduced extracellular pH rcversibly inhibits oligomerization, intracellular transport, and processing of the influenza hemagglutinin in infected Ma-din-Darby canine kidney cells, J Biol Chem 1988;263:11478-11483.
14. Chen SSL, Huang AS: Further characterization of the vesicular stomatitis virus 045 mutant: Intracellular conversion of the glycoprotein to a soluble form, J Virol 1986:59:210-215.
15. Mackctt M, Smith GL, Moss B: The construction and characterization of vaccinia virus recombinants expressing foreign genes: in Glover DM (cd): DNA Cloning, A Practical Approach, Oxford, IRL Press, 1985. vol 2. pp 191-211.
16. Chen SSL, Lee CN, Lee WR, McIntosh K, Lee TH: Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembranc glycoprotein, J Virol 1993;67:3615-3619.
17. Hahn BH, Shaw GM, Arya S, Popovic M, Gallo RC, Wong-Staal F: Molecular cloning and characterization of the HTLV-I11 virus associated with AIDS, Nature 1984:312:166-169.
18. Bertholct C, Drillien R, Witter R: One hundred base pairs of 5' Hanking sequence of a vaccinia virus late gene are sufficient to temporally regulate late transcription, Proc Nall Acad Sci USA 1985;82:2096-2100.
19. Chakrabarti S, Robert-Guroff M, Wong-Staal F, Gallo RC, Moss B: Expression of the HTLV-111 envelope gene by a recombinant vaccinia virus, Nature 1986:320:535-537.
20. Hu SL, Kosowski SG, Dalrymple JM: Expression of AIDS virus envelope gene in recombinant vaccinia viruses, Nature 1986:320:537-540.
21. Lifsor, JD, Fcinbcrg MB, Reyes GR, Rabin L, Banapour B, Chakrabarti S, Moss B, Wong-Staal F, Stcinter KS, Englcman EG: Induction of CD4-dependcnt cell fusion by the HTLV-UI/LAV envelope glycoprotein, Nature 1986; 323:725-728.
22. Kieny MP, Rautmann G, Schmitt D, Dott K, Wain-Hobson S, Alizon M, Girard M, Cha-marct S, Laurent A, Montagnier L, Lecocq JP: AIDS virus env protein expressed from a recombinant vaccinia virus, Bio technology 1986;4:790-795.
23. Barrett N, Mitlerer A, Mundt W, Eibl J, Eibl M, Gallo RC, Moss B, Domer F: Large-scale production and purification of a vaccinia re-combmant-dcrivcd HIV-1 gpl60 and analysis of its immunogenicity, AIDS Res Hum Retroviruses 1989:5:159-171.
24. Ovens RJ, Compans RW: Expression of the human immunodeficiency virus envelope glycoprotein is restricted to basolatcral surfaces of polarized epithelial cells, J Virol 1989:63:978-982.
25. Gelderblom HR, Reupke H, Pauli G: Loss of envelope antigens of HTLV-1II/LAV, a factor in AIDS pathogenesis? Lancet 1985:ii: 1016-1017.
26. Schneider J, Kaadcn O, Copeland TD, Orosz-lan S, Hunsmann G: Shedding and interspecies type sero-reactivity of the envelope glyeopoly-pcptide gpl20 of the human immunodeficiency virus, J Gen Virol 1986;67:2533-2538.
27. McClure MO, Marsh M, Weiss RA: Human immunodeficiency virus infection of CD4-bearing cells occurs by a pH-indcpcndent mechanism, EMBOJ 1988;7:513-518.